Form 8-K - Current report:
SEC Accession No. 0001213900-24-102833
Filing Date
2024-11-26
Accepted
2024-11-26 16:15:11
Documents
17
Period of Report
2024-11-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222380-8k_citius.htm   iXBRL 8-K 29383
2 CERTIFICATE OF CHANGE FILED WITH THE SECRETARY OF STATE OF THE STATE OF NEVADA O ea022238001ex3-1_citius.htm EX-3.1 604
3 PRESS RELEASE, DATED NOVEMBER 22, 2024 ea022238001ex99-1_citius.htm EX-99.1 13303
4 GRAPHIC ex3-1_001.jpg GRAPHIC 846669
5 GRAPHIC ex99-1_001.jpg GRAPHIC 16759
  Complete submission text file 0001213900-24-102833.txt   1414838

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ctxr-20241125.xsd EX-101.SCH 3027
7 XBRL LABEL FILE ctxr-20241125_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ctxr-20241125_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0222380-8k_citius_htm.xml XML 3794
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 241503955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)